Home/ Supplements/ Vitamin D/ Roxy Lemon Drop Flavored

Roxy Lemon Drop Flavored

product on market Softgel Capsule BPI Sports Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 67% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

Vitamin D3 and Niacin are supported by strong evidence for maintaining bone health and cellular energy metabolism. The Roxy Blend has limited clinical data available to verify its specific efficacy. Overall, these ingredients are generally recognized as safe for consumption.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Roxy Lemon Drop Flavored
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Softgel(s)
Serving Size
45
Servings
Other Combinations
Product Type
67%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

2400 IU (600% DV)
4.0× RDA — above typical dose (UL: 0.1 mg) 608 studies (A:16, B:251)
35 mg (175% DV)
2.5× RDA — within safe limits 196 studies (A:5, B:63)
Roxy Blend
370 mg

Other Ingredients

Sunflower Oil Gelatin Glycerin purified Water Beeswax Sunflower Lecithin Titanium Dioxide Tumeric extract Corn Oil Lemon Oil
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Suggested Use: Take one (1) softgel daily, in the morning on an empty stomach before food, or as directed by a qualified healthcare practitioner.

Warnings & Precautions

Due to the extreme potential strength of this product Do Not Exceed more than one (1) softgel per day.

Warnings: Not intended for use by persons under age 18.

Do not exceed recommended dose. Do not take for more than eight (8) consecutive weeks.

Do not use if you are pregnant or nursing.

Discontinue use two weeks prior to surgery or if upset stomach occurs.

Get the consent of a licensed physician before using this product, especially if you are taking medication, have a medical condition, or thinking about becoming pregnant.

Do not take this product close to bedtime.

KEEP THIS PRODUCT AND ALL SUPPLEMENTS OUT OF THE REACH OF CHILDREN.

Caffeine warning: The recommended serving of this product contains approximately as much caffeine as three cups of coffee.

Do not consume caffeine, or combine with synephrine, including but not limited to coffee, tea, soda and other dietary supplements or medications containing phenylephrine or caffeine.

Too much caffeine may cause nervousness, irritability, sleeplessness, and occasionally rapid heartbeat. Discontinue use if you experience dizziness, severe headache, rapid heartbeat or shortness of breath.

Caution: Roxy(TM) contains the B vitamin niacin. Niacin may cause temporary flushing, tingling, skin reddening, and sensations of heat, especially if taken on an empty stomach. This is a common reaction.

Formulation Notes

The recommended serving of this product contains approximately as much caffeine as three cups of coffee.

Roxy(TM) contains the B vitamin niacin.

Additional Information

FAST-ACTING NEW! WEIGHT LOSS* ADVANCED THERMOGENIC SOFTGELS*

Rev. 01-002-RSG001 12/14

When combined with a proper exercise and nutrition regimen. Statements based on early-stage independent 3rd party in vivo and / or in vitro model scientific research data findings for individual ingredients.

EASY TO SWALLOW LEMON DROP FLAVORED SOFTGELS

ENERGY AND FOCUS* WEIGHT LOSS* FAST-ACTING SOFTGELS GREATER BIOAVAILABILITY SUPERIOR DOSAGE ACCURACY NON GENETICALLY MODIFIED

NON GMO

45 SERVINGS

Please read entire label before use.

Metadata

Product Details

UPC / SKU8 11213 02185 6
DSLD Entry Date2015-03-25
Product TypeOther Combinations
FormSoftgel Capsule
DSLD ID43271
Data Updated2026-04-11
Research

Research Evidence

872
Research Sources
53
Avg Quality
309
Meta Analysis
309
Clinical Trial
111
Rct
71
Systematic Review
55
Guideline
4
Cochrane Review
4
Regulatory Source
2
Other
2
Narrative Review
2
Observational
1
Openfda Safety
A Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis
Meta Analysis The Cochrane database of systematic reviews 2009 PubMed DOI
A Vitamin D supplementation for prevention of mortality in adults
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Vitamin D and vitamin D analogues for preventing fractures in post-menopausal women and older men
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Vitamin D supplementation for prevention of cancer in adults
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Interventions for preventing falls in older people in care facilities and hospitals
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Drugs for preventing lung cancer in healthy people
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Vitamin D supplementation for prevention of mortality in adults
Meta Analysis The Cochrane database of systematic reviews 2011 PubMed DOI
A High prevalence of vitamin D deficiency in Asia: A systematic review and meta-analysis
Meta Analysis Critical reviews in food science and nutrition 2023 PubMed DOI
A The effect of vitamin D supplementation on depressive symptoms in adults: A systematic review and meta-analysis of randomized controlled trials
Meta Analysis Critical reviews in food science and nutrition 2023 PubMed DOI
A Interventions for preventing falls in older people living in the community
Meta Analysis The Cochrane database of systematic reviews 2009 PubMed DOI
View all evidence for Vitamin D →
Compare

Similar Products

View all Vitamin D products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.